Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Teppei, MATSUNO"'
Autor:
Akihito Fujimi, Yasuhiro Nagamachi, Naofumi Yamauchi, Naoki Onoyama, Naotaka Hayasaka, Teppei Matsuno, Kazuhiko Koike, Yoshiro Goto, Kohji Ihara, Junji Kato, Takuji Nishisato, Hiroshi Kawase, Tomoyuki Yano, Takayuki Kanaseki, Shintaro Sugita, Masayoshi Kobune
Publikováno v:
Journal of Clinical & Experimental Hematopathology; 2024, Vol. 64 Issue 1, p37-44, 8p
Autor:
Seiya Saito, Syutaro Ooiwa, Teppei Matsuno, Shota Yamada, Toshinori Okuda, Shinya Minami, Yusuke Sugama, Saori Shimoyama, Rie Morita, Ginji Ohmori, Yuji Kanisawa
Publikováno v:
Nihon Naika Gakkai Zasshi. 111:808-816
Autor:
Akihito Fujimi, Yasuhiro Nagamachi, Naofumi Yamauchi, Naoki Onoyama, Teppei Matsuno, Naoya Miyajima, Kazuhiko Koike, Yoshiro Goto, Kohji Ihara, Takuji Nishisato, Masayoshi Kobune
Publikováno v:
Internal medicine (Tokyo, Japan).
TAFRO syndrome, a rare systemic inflammatory disorder, commonly develops in an acute or subacute manner, with an aggressive clinical behavior. A substantial number of cases of TAFRO syndrome presenting with abdominal pain, and adrenal abnormalities o
Autor:
Akihito Fujimi, Yasuhiro Nagamachi, Naofumi Yamauchi, Naoki Onoyama, Teppei Matsuno, Naoya Miyajima, Kazuhiko Koike, Yoshiro Goto, Kohji Ihara, Takuji Nishisato, Masayoshi Kobune
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 11, p1675-1681, 7p
Autor:
Teppei, MATSUNO, Kazuyuki, MURASE, Kohichi, TAKADA, Yutaka, KAWANO Masahiro HIRAKAWA, Koji, MIYANISHI, Masayoshi, KOBUNE, Junji, KATO
Publikováno v:
札幌医学雑誌 = The Sapporo Medical Journal = The Sapporo medical journal. 87(1-6):49-61
Regulatory T cells (Tregs) play an important role in the maintenance of self-tolerance and immune homeostasis. Interleukin-2 (IL-2) is critical for Treg expansion, activity and survival. Previous studies have demonstrated that low-dose IL-2 resulted
Autor:
Tamotsu Sagawa, Masahiro Hirakawa, Koji Miyanishi, Motoh Ohi, Yasushi Sato, Teppei Matsuno, Chisa Fujita, Koshi Fujikawa, Tatsuya Ito, Masanori Sato, Masayoshi Kobune, Takayuki Nobuoka, Ichiro Takemasa, Yutaka Okagawa, Michiaki Hirayama, Hiroyuki Ohnuma, Takahiro Osuga, Yasushi Tsuji, Junji Kato, Naotaka Hayasaka
Publikováno v:
Cancer Science
Cisplatin plus 5‐fluorouracil is regarded as standard neoadjuvant chemotherapy for esophageal squamous cell carcinoma (ESCC) in Japan, but the prognosis remains poor. We have previously described how definitive chemoradiotherapy with docetaxel, ned
Autor:
Kazuyuki Murase, Kazuma Ishikawa, Naotaka Hayasaka, Hajime Nakamura, Koji Miyanishi, Junji Kato, Teppei Matsuno, Yutaka Kawano, Kohichi Takada, Kunihiro Takanashi, Masayoshi Kobune, Shingo Tanaka, Shinichi Katsuki, Hiroki Sakamoto
Publikováno v:
Kanzo. 59:180-186
Autor:
Shogo Miura, Fumito Tamura, Makoto Yoshida, Naoki Uemura, Yohei Arihara, Junji Kato, Masahiro Hirakawa, Koji Miyanishi, Naoki Hayasaka, Yutaka Okagawa, Teppei Matsuno, Satoshi Iyama, Rishu Takimoto, Takahiro Osuga, Tsutomu Sato, Masayoshi Kobune, Kohichi Takada, Yasushi Sato, Michihiro Ono
Publikováno v:
Oncotarget
Complete remission by induction therapy in acute myelogenous leukemia (AML) can be achieved due to improvements in supportive and optimized therapy. However, more than 20% of patients will still need to undergo salvage therapy, and most will have a p
Autor:
Hiroyuki, Kuroda, Wataru, Jomen, Masahiro, Yoshida, Makoto, Usami, Michiko, Yamada, Tomoyuki, Abe, Tamaki, Sakurai, Shigeyuki, Fujii, Masahiro, Maeda, Teppei, Matsuno, Masanori, Sato, Yusuke, Kanari, Junji, Kato
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 41(9)
BiRd combination therapy, which comprises clarithromycin (CAM: Biaxin®), lenalidomide (LEN: Revlimid®), and dexamethasone ( DEX), is a highly effective treatment for newly diagnosed symptomatic myeloma. However, its efficacy against recurrent myelo
Autor:
Masanori, Sato, Hiroyuki, Kuroda, Masahiro, Yoshida, Makoto, Usami, Tomoyuki, Abe, Tamaki, Sakurai, Shigeyuki, Fujii, Masahiro, Maeda, Miri, Fujita, Yusuke, Kanari, Teppei, Matsuno, Wataru, Jomen, Junji, Kato
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 55(8)
Primary hepatosplenic CD5-positive diffuse large B cell lymphoma (CD5⁺ DLBCL) has recently been characterized as showing hepatosplenomegaly without lymphadenopathy, a portal and intrasinusoidal pattern of infiltration in the liver, and bone marrow